Composite functional genetic and comedication CYP2D6 activity score in predicting tamoxifen drug exposure among breast cancer patients.

Journal of clinical pharmacology

Volumn 50, Issue 4, 2010, Pages 450-458

  Borges, Silvana ^a   Desta, Zeruesenay ^b   Jin, Yan ^b   Faouzi, Azzouz ^b   Robarge, Jason D ^b   Philips, Sanosh ^b   Nguyen, Anne ^b   Stearns, Vered ^b   Hayes, Daniel ^b   Rae, James M ^b   Skaar, Todd C ^b   Flockhart, David A ^b   Li, Lang ^b  

^a INDIANA UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOCHROME P450 2D6; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST TUMOR; COMPARATIVE STUDY; ENZYME ACTIVATION; ENZYMOLOGY; FEMALE; GENETICS; GENOTYPE; HUMAN; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; REGISTER;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CYTOCHROME P-450 CYP2D6; ENZYME ACTIVATION; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REGISTRIES; TAMOXIFEN;

MLCS; MLOWN;

EID: 77956255908     PISSN: None     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270009359182     Document Type: Article

References (0)